Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
Next >
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
↗
Today 14:25 EDT
Via
The Motley Fool
Tickers
ABVX
BEAM
IMVT
PTGX
ROIV
Exposures
Lead
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
↗
Today 14:10 EDT
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
Tickers
ABVX
CRNX
IMVT
PTGX
ROIV
Exposures
Lead
Legal
Regulatory
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
CELC
CRVS
KOD
KYMR
RVMD
TNGX
Exposures
Lead
Legal
Regulatory
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
CELC
KOD
KYMR
RVMD
TNGX
Exposures
Lead
Legal
Regulatory
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
↗
May 17, 2026
Via
The Motley Fool
Tickers
ABVX
COGT
MAZE
PRAX
SYRE
Exposures
Lead
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
ABVX
COGT
GPCR
PRAX
SYRE
Exposures
Lead
Legal
Regulatory
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
↗
May 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
BBOT
ERAS
EWTX
EYPT
PRAX
Exposures
Lead
Legal
Regulatory
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
↗
May 16, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
DRUG
ERAS
PRAX
TERN
TNGX
WHWK
Exposures
Lead
Legal
Regulatory
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
↗
May 16, 2026
Via
The Motley Fool
Tickers
ARGX
COGT
INSM
NKTR
ONC
ROIV
Exposures
Lead
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700%
↗
May 14, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
ERAS
EWTX
KYMR
ONC
SRRK
Exposures
Lead
Legal
Regulatory
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
↗
May 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
DNTH
ELVN
JBIO
ORKA
Exposures
Lead
Legal
Regulatory
Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story
↗
May 10, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
CAPR
Exposures
Lead
Legal
Regulatory
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug
↗
May 10, 2026
Via
The Motley Fool
Tickers
ALMS
CELC
CVX
KRYS
TGTX
XOM
Exposures
Lead
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
↗
May 07, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
MAZE
Exposures
Lead
Legal
Regulatory
Onto (ONTO) Q1 2026 Earnings Transcript
↗
May 05, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Tickers
ONTO
Exposures
Artificial Intelligence
Lead
Supply Chain
Coral Gables Lead Outreach, Prospecting & Qualification: Expert Service Announce
April 25, 2026
Via
Press Release Distribution Service
Exposures
Lead
Stop Smoking Hypnosis in Orlando, FL Helps 63-Year-Old End a 40+ Year, 2-Pack-a-Day Habit After Just One Session
April 17, 2026
Via
AB Newswire
Exposures
Lead
The Chicago Marketing Agency Helps Businesses Scale Faster with Data-Driven Digital Marketing Solutions
April 15, 2026
Via
Get News
Exposures
Lead
Zambuki Introduces AI-Powered Roofing Leads Service for Contractors
April 15, 2026
Via
Press Advantage
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lead
Block Co-Founder Foresees AI Doing Middle Management Tasks
April 08, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
QBTS
Exposures
Artificial Intelligence
Lead
Aehr Test (AEHR) Q3 2026 Earnings Call Transcript
↗
April 08, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
Tickers
AEHR
Exposures
Artificial Intelligence
Financial
Lead
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More
↗
April 04, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
IMNM
Exposures
Lead
Legal
Product Safety
SpaceX Files for Historic $1.75 Trillion IPO Amid xAI Merger and Artemis II Launch
April 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Tickers
BA
BABA
BAC
C
GS
JPM
Exposures
Artificial Intelligence
Economy
Lead
RockBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Explores Multi-Vein Potential at Idaho Clayton Project
April 01, 2026
Via
Investor Brand Network
Tickers
CSE:CXC
CXXMF
Exposures
Lead
Use of bronze bushings in the production of machine tools and equipment of machine-building enterprises
April 01, 2026
Via
AB Newswire
Topics
Supply Chain
Exposures
Lead
Supply Chain
Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares
↗
March 27, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
STOK
Exposures
Lead
Legal
Regulatory
MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know
↗
March 26, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
MBX
Exposures
Lead
Legal
Regulatory
Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's What Really Matters for Investors
↗
March 26, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
APGE
Exposures
Lead
Legal
Regulatory
Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally
↗
March 24, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
STOK
Exposures
Lead
Legal
Regulatory
CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Sees Important Geological Indicators for Advancing Clayton Silver Project Exploration
March 24, 2026
Via
Investor Brand Network
Tickers
CSE:CXC
CXXMF
JPM
Exposures
Lead
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.